Spiro-indenes and spiro-1,2-dihydro-naphthalenes for...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/233, 260/315

C07D 235/02 (2006.01) C07D 263/52 (2006.01) C07D 277/60 (2006.01)

Patent

CA 1244443

SPIRO-INDENES AND SPIRO-1,2-DIHYDRO-NAPHTHALENES FOR TREATMENT OF DIABETIC COMPLICATIONS Abstract Spiro-oxazolidinones, -thiazolidinones and -imidazo- lidinones are disclosed which are useful as aldose reductase inhibitors and as therapeutic agents for the treatment of complications arising from diahetes. Pharmaceutical compositions containing the spiro compounds and a method of treating diabetic complications are also disclosed. Those compounds have the formula: Image wherein U is oxygen, sulfur or nitrogen substituted with hydrogen n is zero or one; X is hydrogen or alkyl having 1-4 carbon atoms: Y is hydrogen, halo, nitro, trifluoromethyl, hydroxy, alkoxy or alkylthio having,1-4 carbon atoms or alkyl 1 having 1-4 carbon atoms; Z is hydrogen, halo, nitro trifluoromethyl, hydroxy, alkoxy having 1-4 carbon atoms or alkyl having 1-4 carbon atoms, with the proviso that if either Y or Z is nitro the other is hydrogen or pharmaceutically acceptable salts thereof.

477079

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Spiro-indenes and spiro-1,2-dihydro-naphthalenes for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Spiro-indenes and spiro-1,2-dihydro-naphthalenes for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiro-indenes and spiro-1,2-dihydro-naphthalenes for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1191369

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.